Clinical Trial Update: A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial completed to evaluate the cholesterol-lowering effects of two marketed products in patients with Type 2 diabetes mellitus and hypercho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Organon and Co | Conditions: Type 2 Diabetes Mellitus, Hypercholesterolemia | Phase 3 | Status: COMPLETED